Health and Fitness Health and Fitness
Tue, November 2, 2010
[ Tue, Nov 02nd 2010 ] - Market Wire
ImmunoGen, Inc. Announces Presentations at the 22 .. sium on Molecular Targets and Cancer Therapeutics
[ Tue, Nov 02nd 2010 ] - Market Wire
Pro-Pharmaceuticals to Receive $489,000 in Federa .. tin-Targeting Cancer and Liver Fibrosis Compounds
[ Tue, Nov 02nd 2010 ] - Market Wire
RXi Pharmaceuticals Awarded $1 Million in IRS Grants to Advance RNAi Therapeutics
[ Tue, Nov 02nd 2010 ] - Market Wire
GTx, Inc. Announces Third Quarter 2010 Financial Results Conference Call and Webcast
[ Tue, Nov 02nd 2010 ] - Market Wire
Inhibitex Announces Data Presentations at the 61s .. can Association for the Study of Liver Diseases (
[ Tue, Nov 02nd 2010 ] - Market Wire
Ligand Awarded $2 Million from U.S. Government Un .. er the Patient Protection and Affordable Care Act
[ Tue, Nov 02nd 2010 ] - Market Wire
Celldex Reports Third Quarter 2010 Financial Results
[ Tue, Nov 02nd 2010 ] - Market Wire
Corgenix to Host Conference Call to Discuss First Quarter Results
[ Tue, Nov 02nd 2010 ] - Market Wire
Three POZEN Projects Selected for Therapeutic Discovery Grants
[ Tue, Nov 02nd 2010 ] - Market Wire
Viread® gegen Hepatitis B hlt antivirale Suppres .. stenzen ber einen Behandlungszeitraum von vier Ja
[ Tue, Nov 02nd 2010 ] - Market Wire
Viread® voor hepatitis B behoudt antivirale supp .. van resistentie gedurende behandeling van 4 jaar
[ Tue, Nov 02nd 2010 ] - Market Wire
SurModics to Webcast Fourth Quarter and Fiscal Year 2010 Earnings Conference Call November 10
[ Tue, Nov 02nd 2010 ] - Market Wire
GenMark Diagnostics Acquires License to HCV Genotyping Patent Estate
[ Tue, Nov 02nd 2010 ] - Market Wire
Array BioPharma to Report Financial Results for t .. First Quarter of Fiscal 2011 on November 8, 2010
[ Tue, Nov 02nd 2010 ] - Market Wire
Los compuestos en fase de investigacin GS 9190 y .. tamiento de la hepatitis C en combinacin con trat
[ Tue, Nov 02nd 2010 ] - Market Wire
Insight Imaging Reports Discussions on Potential Restructuring Plan
[ Tue, Nov 02nd 2010 ] - Market Wire
Teva Reports Record Third Quarter 2010 Results
[ Tue, Nov 02nd 2010 ] - Market Wire
Notice of Medical Facilities Corporation';s Fisca .. 0 Third Quarter Financial Results Conference Call
[ Tue, Nov 02nd 2010 ] - Market Wire
WellCare Board Adopts Majority Voting Standard for Director Elections
[ Tue, Nov 02nd 2010 ] - Market Wire
Osiris Therapeutics Announces Third Quarter 2010 Financial Results Conference Call
[ Tue, Nov 02nd 2010 ] - Market Wire
Emeritus Closes on Previously Announced Leases for 27 Senior Living Communities
[ Tue, Nov 02nd 2010 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation Rela .. Acquisition of Cardiac Science Corporation - CSCX
[ Tue, Nov 02nd 2010 ] - Market Wire
Aeolus Pharmaceuticalsa? AEOL 10150 Promotes Surv .. man Primates Exposed to Lethal Doses of Radiation
[ Tue, Nov 02nd 2010 ] - Market Wire
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Qua .. er 2010 Financial Results Call Set for November 9
[ Tue, Nov 02nd 2010 ] - Market Wire
Tolerx Forms Scientific Advisory Board to Advance Research in Type 1 Diabetes
[ Tue, Nov 02nd 2010 ] - Market Wire
Coventry Health Care, Expeditors International, A .. source Bergen, Principal Financial and Kellogga?s
[ Tue, Nov 02nd 2010 ] - Market Wire
Neurocrine Biosciences, Jacobs Engineering, Ford, Kellogg and Honda Motor Co.
[ Tue, Nov 02nd 2010 ] - Market Wire
DUSA Pharmaceuticals, Inc.® to Host Third Quarte .. Highlights and Financial Results Conference Call
Mon, November 1, 2010
[ Mon, Nov 01st 2010 ] - Market Wire
Prestige Brands Holdings, Inc. Completes Purchase of Blacksmith Brands
[ Mon, Nov 01st 2010 ] - Market Wire
Biomagnetics Completes Audit and Financial Review

Biomagnetics Completes Audit and Financial Review


Published on 2010-11-01 08:05:12 - Market Wire
  Print publication without navigation


SAN FRANCISCO--([ BUSINESS WIRE ])--Biomagnetics Diagnostics Corp., (PINK SHEETS:[ BMGP ]) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the completion of its full audit and financial review, which was conducted by Seale & Beers Certified Public Accounts, LLC.

"I am pleased that the audit has now been completed and that we are moving toward full reporting status with the U.S. Securities & Exchange Commission. We are excited about the future for Biomagnetics and we want to make sure all of our investors and shareholders have full transparency into our operations," commented Clayton Hardman, CEO of Biomagnetics.

About Biomagnetics Diagnostics Corp.

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company and an acquirer of other innovative technologies. More information on Biomagnetics Diagnostics Corp. can be seen at [ www.biomagneticsbmgp.com ].

Contributing Sources